In recent weeks, a slew of newly enacted health laws or revised interpretations emerged. Despite the changes, the means to...
Read moreSome critics have raised concerns about potential unintended consequences of the proposed ban, particularly for African American menthol smokers.
Read moreNearly 80% of chronic mental health conditions emerge in childhood, and when help is eventually sought, it is often years...
Read moreA draft leak of Justice Alito's interpretation of abortion references 16th century common law, when abortion was illegal. It changes...
Read moreThe most controversial healthcare laws simplify complex issues through vague legal terms. Opioids and abortions have similar levels of outrage...
Read moreWe discuss health policy in terms of rights. Instead, the medical community must challenge the notion that patient behavior can...
Read moreMany public health and addiction experts promote the “harm reduction” tactic to help prevent overdose deaths.
Read moreSince Vaught’s arrest in 2019, there have been at least seven other incidents of hospital staffers searching medication cabinets with...
Read moreThe CDC and DOJ make for curious bedfellows. They should be different organizations. But now, personal health is public policy...
Read moreThe pandemic might be waning, but the medical innovations continue churning, creating an odd disconnect in healthcare. It highlights the...
Read moreThe CDC recently announced that it is evaluating its current organizational structure. We hope this leads to much needed changes,...
Read moreThe constant back and forth of rules can be frustrating, but policy changes aren’t usually a sign of mistakes. Rather,...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy